2.Analysis of the Utilization of Antidepressant Drugs in 11 Hospitals from Zhejiang Province during 2013-2017
China Pharmacy 2019;30(5):704-707
OBJECTIVE: To investigate the application of antidepressants in Zhejiang province and to provide reference for rational drug use in clinic. METHODS: WHO-recommended defined daily dose (DDD) method was used to statistically analyze consumption sum, main types, defined daily dose system (DDDs), daily drug cost (DDC) and ranking ratio (B/A value, i.e. consumption sum rank/DDDs rank, B/A<1 means the price of drugs was higher, whereas the price of drugs was lower) of antidepressant drugs in 11 hospitals from Zhejiang province during 2013-2017. RESULTS: The consumption sum of antidepressants was increased year by year in 11 hospitals from Zhejiang during 2013-2017, and increased from 3 235 200 yuan in 2013 to 4 569 100 yuan in 2017; the proportion of consumption sum of antidepressants in total consumption sum of all drugs kept stable, ranging from 0.47% to 0.50%. The top 5 drugs by consumption sum were fluoxetine, duloxetine, olanzapine and venlafaxine; consumption sum of escitalopram accounted for a larger increase (proportion ration increased from 8th place in 2013 to first place in 2017). Within 5 years, DDDs of fluoxetine, paroxetine and sertraline took up the first 3 place; DDC of olanzapine, quetiapine and duloxetine took up the first 3 place; the drugs with B/A value<1 included duloxetine, olanzapine, venlafaxine and quetiapine, etc; the drugs with B/A value>1 were paroxetine and sertraline. CONCLUSIONS: The use of antidepressant drugs in 11 hospitals from Zhejiang province is rational in structure; selective 5-hydroxytryptamine (5-HT) reuptake inhibitors (SSRI), selective 5-HT and noradrenaline reuptake inhibitor (SNRI) take up the predominant place. New antidepressant drug escitalopram shows a good clinical prospect.
3.Application of WCX magnetic bead for serum proteome profiling in cervical squamous cell carcinomas and its clinical significance
Zhiguo ZHENG ; Ting XIA ; Yongzhe LI ; Yun GAO ; Hanzhou MOU ; Shenhua XU ; Yang XU
Basic & Clinical Medicine 2006;0(03):-
Objective To analyze the serum proteomic pattern of the cervical cancer patients,to develope diagnostic model and to evaluate its clinical significance.Methods WCX magnetic bead and MALDI-TOF were used to detect the serum proteomic pattern of 77 patients with cervical squanmous cell carcinomas,13 patients with CINⅢ and 52 healthy women.Biomarker Wizard software was used to detect protein peaks and potential difference between cervical cancer and controls.The model was developed by Biomarker Patterns software.Results A diagnostic pattern consisting of three differential protein peaks was established with 100%(32/32)sensitivity and 93.8%(30/32)specificity.A sensitivity of 77.8%(35/45)and a specificity of 75%(15/20)in blind test were obtained.The diagnostic model also could discriminate CINⅢ and SCC-Ag negative patients from controls.Conclusion The diagnostic pattern combining 3974,3398,13732m/z protein peaks can discriminate not only cervical squamous cell cancer but also CINⅢ and SCC-Ag negative patients from controls.
5. Clinical diagnosis and treatment of three cases with hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
Hanzhou GUAN ; Yuan DING ; Dongxiao LI ; Hui DONG ; Jinqing SONG ; Ying JIN ; Zhijun ZHU ; Liying SUN ; Yanling YANG
Chinese Journal of Pediatrics 2017;55(6):428-433
Objective:
To study the clinical characteristics, methods of diagnosis and treatment of hyperornithinemia-hyperammonemia- homocitrullinuria (HHH) syndrome.
Method:
From July 2011 to August 2016, 3 Chinese patients with HHH syndrome were enrolled in this study. The clinical course, biochemical features, brain MRI findings, and gene mutations were analyzed.
Result:
The three patients′ age at onset of symptoms was 3 months to 7 years, and the age of diagonosis was 3 years and 10 months to 9 years and 10 months. All of them presented with intolerance to protein-rich foods from the infant period, development retardation and abnormal posture. Case 1 and 2 had moderate mental retardation. Serum ammonia 25-276 μmol/L (reference range<60 μmol/L), alanine aminotransferase (ALT) 20-139 IU/L (reference range 9-50 IU/L), ornithine 29.12-99.44 μmol/L(reference range 15-100 μmol/L), urinary orotic acid 1.49-29.75 mmol/mol Cr (reference range 0-7 mmol/mol Cr), uracil 6.09-103.97 mmol/mol Cr (reference range 0-1.5 mmol/mol Cr). The cranial MRI revealed lesions in the basal ganglia, abnormal white matter signal, progressive demyelination and cerebral atrophy. On their SLC25A15 gene, a novel homozygous missense mutation c. 416A>G (p.E139G) was identified in case 1, a known pathogenic homozygous nonsense mutation c. 535C>T was found in case 2 and 3. Liver transplantation had been performed when case 1 was 6 years old. Significant improvements were observed in dietary habit, mental and motor functions, and biochemical parameters. After the dietary intervention with the supplements of arginine, L-carnitine, case 2 was improved, spastic paraplegia of case 3 had no mitigation. Liver transplant was recommended.
Conclusion
HHH syndrome has an aversion to protein-rich food, and the patients have recurrent vomiting and progressive neurological dysfunction. Clinical diagnosis of HHH syndrome is difficult and patients may present with incomplete biochemical phenotype. The genetic analysis is key for the diagnosis. Depending on their condition, individuals with HHH syndrome can be treated with a low-protein diet, drugs and liver transplantation.
6.Clinical features and prognosis of purulent meningitis in premature infants versus full-term infants
Hanzhou GUAN ; Hai LI ; Yingchao FAN ; Ying GUO ; Xinhua ZHANG
Chinese Journal of Primary Medicine and Pharmacy 2021;28(8):1164-1167
Objective:To investigate clinical features and prognosis of purulent meningitis in premature infants versus full-term infants and to better understand purulent meningitis and improve the diagnosis and treatment of purulent meningitis in infants. Methods:The clinical data of 54 infants with purulent meningitis who received treatment in Shanxi Children's Hospital, China between January 2017 and December 2019 were included in this study. The included infants were divided into preterm group (gestational age < 37 weeks, n = 11) and full-term group (gestational age 37-42 weeks, n = 43) according to different gestational ages. Clinical features and cerebrospinal fluid biochemical indexes (white blood cell count, protein concentration, glucose level) as well as total effective rate were compared between the preterm and full-term groups. Results:The main clinical features of neonatal purulent meningitis were fever, bradykinesia, low amount of milk intake, convulsion, lethargy, irritability, increased intracranial pressure, hypotonia or hypertonia. Hypotonia was the prominent manifestation in the preterm group, while fever, convulsion and bradykinesia were the prominent manifestations in the full-term group. White blood cell count and cerebrospinal fluid glucose level in the preterm group were significantly higher than those in the full-term group ( t = 2.215, 2.023, both P < 0.05), but cerebrospinal fluid protein level in the preterm group was significantly higher than that in the full-term group ( t = 2.437, P < 0.05). There was no significant difference in total effective rate between preterm and full-term groups [90.91% (10/11) vs. 90.70% (39/43), χ2 = 0.001, P > 0.05]. Conclusion:The clinical features of neonatal purulent meningitis are not specific, and the clinical features of premature infants with purulent meningitis are not typical. It is necessary to carefully observe the clinical manifestations of premature infants with purulent meningitis and detect the biochemical indexes of cerebrospinal fluid to strive for early diagnosis and treatment.
8.Epidemiological surveillance of leptospirosis in 1997-2002 in Zhejiang Province.
Zhen-yu GONG ; Li-peng JIANG ; En-fu CHEN ; Zhen WANG ; Jun-fen LI ; Gui-ming FU ; Cheng-liang CAI ; Feng-hua XU
Chinese Journal of Epidemiology 2004;25(12):1091-1091
Adolescent
;
Adult
;
China
;
epidemiology
;
Disease Outbreaks
;
Female
;
Humans
;
Incidence
;
Leptospirosis
;
epidemiology
;
mortality
;
Male
;
Middle Aged
9.Chinese Medicine Regulating TGF-β1/Smad Signaling Pathway in Treatment of Diabetic Nephropathy: A Review
Baochao PAN ; Hanzhou LI ; Hui ZHANG ; Yimeng LI ; Weibo WEN ; Shuquan LYU
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(23):237-249
Diabetic nephropathy (DN) is one of the most serious microvascular complications of diabetes and the leading cause of end-stage kidney disease. The onset and progression of DN are linked to the progression of renal fibrosis which is an important pathological feature and final pathological result of various chronic kidney diseases. As a result, therapies against renal fibrosis can help delay the progression of DN. The transforming growth factor-β1 (TGF-β1)/Smad signaling pathway is one of the key pathways in renal fibrosis. TGF-β1, a crucial mediator of renal fibrosis, is highly expressed in the case of fibrosis-associated kidney diseases, and Smads are the main effectors in the TGF-β1 signal transduction pathway. By activating Smads, TGF-β1 transports signals from the cytoplasm to the nucleus and regulates the transcription of fibrosis-related target genes, thus exerting the biological effects and promoting the progression of renal fibrosis. In recent years, Chinese medicine has become prominent in the prevention and treatment of DN, and there has been an explosion of research on Chinese medicine in the prevention and treatment of DN through the TGF-β1/Smad signaling pathway. Based on literature research, this paper reviewed the basic structure of the TGF-β1/Smad signaling pathway, the relationship with DN, and monomers and extract of Chinese medicine, Chinese patent medicine, and compound Chinese medicine prescriptions in improving and delaying the renal fibrosis based on the TGF-β1/Smad signaling pathway, and in alleviating inflammatory response and oxidative stress, reducing the accumulation of extracellular matrix, and inhibiting epithelial-mesenchymal transition by regulating the TGF-β1/Smad signaling pathway. Thereby, this study is expected to provide new mindset for the treatment of DN.